Determination of Factor V Leiden Mutation and R2 Polymorphism in Cis Position

被引：5
|
作者：
Ozturk, Aysenur [1 ]
Balli, Sezen [1 ]
Akar, Nejat [1 ]
机构：
[1] Ankara Univ, Pediat Genet Dept, TR-06100 Ankara, Turkey
来源：
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2013年 / 19卷 / 06期
关键词：
thrombosis; FV gene; mutation; polymorphism; ACTIVATED PROTEIN-C; 1691; G-A; VENOUS THROMBOSIS; TURKISH POPULATION; HR2; HAPLOTYPE; RISK; RESISTANCE; GENE; THROMBOEMBOLISM;
D O I：
10.1177/1076029612445916
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FVA4070G (R2 polymorphism) influences plasma factor V (FV) concentration and was associated with mild activated protein C resistance. This polymorphism was reported to have a trans inheritance with FV Leiden (FVL) mutation. The aim of this study is to investigate the inheritance of R2 polymorphism in the homozygous FVL carriers. In this study, 99 patients with thrombosis and 7 individuals without a history of thrombosis all of which homozygous for FVL were included. Of 99 patients, 1 was heterozygous for FV A4070G. Additionally, 6 polymorphisms in the FV gene were analyzed for the heterozygous R2 patient and her family. When the allelic distribution was classified, 8 different haplotypes were obtained. In contrast to the literature, it was shown that R2 polymorphism could be inherited in cis position with FVL and also the family members could have co-inheritance of the FVL and R2 on the same chromosome as proband.
引用
收藏
页码：685 / 688
页数：4
相关论文
共 50 条
  • [1] Relationship between factor v leiden and the factor v r2 haplotype (A4070G).
    Donnelly, JG
    Shirley, F
    Detombe, S
    CLINICAL CHEMISTRY, 2001, 47 (06) : A105 - A106
  • [2] Thrombin generation test at R2 polymorphism of factor V
    Prochazkova, J.
    Slavik, L.
    Prochazka, M.
    Ulehlova, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 703 - 703
  • [3] A new polymorphism (new mutation?) in the factor V gene of a patient carrying the factor V Leiden mutation
    Lambropoulos, A
    Kouidou, S
    Foka, Z
    Gerotziafas, G
    Kotsis, A
    Makris, PE
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2509 - P2509
  • [4] Determination of an efficient testing algorithm for the factor V Leiden (G1691A) and the factor V R2 (A4070G) mutations.
    Popov, JM
    Buller, A
    Shah, A
    Qu, K
    Olson, S
    Kephard, D
    Strom, CM
    Sferruzza, A
    CLINICAL CHEMISTRY, 2002, 48 (06) : A157 - A157
  • [5] Factor V leiden and factor V R2 allele: High-throughput analysis and association with venous thromboembolism
    Benson, JM
    Ellingsen, D
    El-Jamil, M
    Jenkins, M
    Miller, CH
    Dilley, A
    Evatt, BL
    Hooper, WC
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) : 1188 - 1192
  • [6] Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population
    Zaatari, Ghazi S.
    Otrock, Zaher K.
    Sabbagh, Amira S.
    Mahfouz, Rami A. R.
    PATHOLOGY, 2006, 38 (05) : 442 - 444
  • [7] Factor v Leiden mutation and preeclampsia
    Rigó, J
    Nagy, B
    Fintor, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) : 853 - 853
  • [8] Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation
    Ymir Saemundsson
    Signý Vala Sveinsdottir
    Henrik Svantesson
    Peter J. Svensson
    Journal of Thrombosis and Thrombolysis, 2013, 36 : 324 - 331
  • [9] The distribution of Factor V Leiden mutation
    Eroglu, Aydan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 36 (03) : 341 - 342
  • [10] Tamoxifen and the Factor V Leiden Mutation
    Cuzick, Jack
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13) : 918 - U1
12345